- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02564419
Brain Machine Interface (BMI) in Subjects Living With Quadriplegia (BMI)
Early Feasibility Study of a Medtronic Activa PC+S System for Persons Living With Spinal Cord Injury
In this study, investigators will show proof-of-concept that brain signals can be used in real-time, closed-loop mode to trigger stimulation for hand function. Subjects will undergo surgery to implant a unilateral subdural strip electrode (Resume II, Model 3587A) over the motor cortex. These electrodes implanted in the brain will enable bioelectrical data recording (sensing) from the brain to the implanted Activa PC+S. The cortical sensing data will be
- either processed in the Activa PC+S; or
- off-loaded via the Nexus D communication device (Medtronic) to a computer.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami School of Medicine/Miami Project to Cure Paralysis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- AIS Grades A & B
- Level of Injury C5 or C6
- Local Community dwelling
- Stable chronic injury
- Stable health status and upper extremities
- Completion of Clinical Protocol 01
Exclusion Criteria:
- Coagulopathy
- Anticoagulation
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Medtronic Activa PC+S
Objective of this pilot phase early feasibility study is to assess the safety and feasibility of Medtronic Activa PC+S implant (device) by;
These are important first steps towards creating and designing a device that can enhance or assist in performing activities of daily living (ADL) in the life of these subjects. Attachment 15.3 |
Upon consent, the good candidates will undergo surgical screening that includes a full neurological workup and baseline functional assessment.
Subjects that demonstrate feasibility for control will undergo surgery for unilateral implantation of the Activa PC+S as well as the implantation of unilateral subdural strip electrodes (Resume II, model 3587A) over the motor cortex.
After 24 hour observation in the hospital, subjects will participate in 24 distinct sessions or visits of testing over a 3-6 month period.
During these visits, the sensing, decoding of the implanted device (Activa PC+S) as well as the external stimulation components (Bioness H200) and parameters will be tested and benchmarked.
Subjects will participate for 24 sessions and continue to participate in the study until the end of life of the device, at which point the subject may elect to undergo an explant at that time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
AIS Motor Score
Time Frame: Up to 2 years
|
American Spinal Injury Association (ASIA) Impairment Scale (AIS) Motor scores has a score totaling 0-50 for the upper limbs and 0-50 for the lower limbs with the lower score indicating greater motor impairment
|
Up to 2 years
|
|
AIS Sensory Score
Time Frame: Up to 2 years
|
AIS Sensory scores has a score totaling 0-56 points for light touch and pin prick modalities for a total of a maximum of 112 points per side of the body.
The lower scores indicate greater sensory impairment.
|
Up to 2 years
|
|
SF-36 scores
Time Frame: Up to 2 years
|
Short Form 36 (SF-36) is a 36 item self-report health questionnaire
|
Up to 2 years
|
|
Muscle Force Test
Time Frame: Up to 2 years
|
0. No movement;1.Palpable contraction, no visible movement; 2. Movement but only with gravity eliminated; 3. Movement against gravity; 4. Movement against resistance but weaker than normal; 5. Normal power
|
Up to 2 years
|
|
Range of Motion
Time Frame: Up to 2 years
|
Joint Range of Motion for both active and passive for Flexion and extension
|
Up to 2 years
|
|
SCIM III (Spinal Cord Independence Measure)
Time Frame: Up to 2 years
|
Self-report independence for daily activities of living scored from 1-6
|
Up to 2 years
|
|
JTT Hand Function Test
Time Frame: Up to 2 years
|
Functional timed activities such as hand writing, page turning, lifting small objects, feeding, stacking checkers, lifting light cans and lifting heavy cans
|
Up to 2 years
|
|
Pinch Grip Strength
Time Frame: Up to 2 years
|
Measurement of grip strength throughout training
|
Up to 2 years
|
|
Modified Ashworth Scale
Time Frame: Up to 2 years
|
Muscle tone scored during stretch from 0 to 5
|
Up to 2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jonathan R Jagid, MD, University of Miami
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20150244
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.